% Expired Patents = 50.0

Forward Citations = 31

Loading Chart...

4 inventors (with patents filed for the assignee):

Rima Kaddurah-Daouk (4 out of 29 patents)

Ghaleb Daouk (1 out of 2 patents)

M Flint Beal (1 out of 5 patents)

4. Beverly A Teicher (1 out of 9 patents)

4 patents: Sort by Forward Citations

1. 7285573 - Use of creatine or creatine analogs for the treatment of diseases of the nervous system (2007-10-23),

2. 7186754 - Use of creatine or creatine compounds for skin preservation (2007-03-06),

3. 6075031 - Use of creatine analogues and creatine kinase modulators for the (2000-06-13),

4. 5998457 - Creatine analogues for treatment of obesity (1999-12-07),

Company Overview

Avicena Group, Inc. is a leading provider of innovative healthcare solutions. With a focus on advanced technology and patient care, we offer a range of products and services to improve the quality of life for individuals and communities. Our team is dedicated to driving innovation and excellence in the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#361 in Palo Alto, CA

#14,058 in California

#60,671 in US

Palo Alto, CA, United States of America

Avicena Group, Inc.

Forward Citations = 31

4 inventors:

Rima Kaddurah-Daouk (4 out of 29 patents)

Ghaleb Daouk (1 out of 2 patents)

M Flint Beal (1 out of 5 patents)

4. Beverly A Teicher (1 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avicena Group, Inc.. Retrieved from https://idiyas.com/company/avicena-group

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]